Abstract:【Objective】 Ezrin has been proved to play a significant role in the metastasis of malignant tumors.Antisense molecules can be inaccessible when the complementary target sequences of mRNA are sequestered in secondary structure.So the antisense technologies are often ineffective.To identify the primary and secondary structure and effective target sites of Ezrin mRNA for antisense technology is the purpose of this study.【Methods】 Two RNA folding computer programs,RNAdraw and RNAstructure,were used to predict the Ezrin mRNA primary and secondary structure.Single strand regions of at least four consecutive unpaired bases in Ezrin mRNA secondary structure were chosen to be the target sequences.The target sites which the four classes antisense molecules including antisense oligonucleotides(AsODNs),Ribozyme,DNAzyme and short interfering RNA(SiRNA) binding to were designed according to these single strand regions.These designed target sites were screened by program OligoWalk which based on the principle of minimum free energy.The low minimum free energy of antisense molecule-target sequence duplexes was selected as the result.【Results】 AsODNs had 17 target sites,Ribozyme had 5 target sites,DNAzyme had 15 target sites,SiRNA had 10 target sites.Among these target sites,G1749-A1771 and C1777-G1794 were the perfect target sites of AsODNs because of the lower free energy of AsODNs-target sites duplexes.In the same way,A2359-G2360 was the perfect target site of Ribozyme,A1789-U1790,A1756-G1757 and A1784-G1785 were the perfect target sites of DNAzyme,G802-G808,G1749-A1771 and A2354-G2360 were the perfect target sites of SiRNA.Furthermore,A2354-G2360 was the common target site of the four antisense technologies.【Conclusion】 These results may provide a rational,efficient method for Ezrin mRNA knockdown and inhibit the metastasis of malignant tumors with antisense technology.

Primary and secondary structure analysis and antisense technology target sites designation of Ezrin mRNA

Ezrin Mrna Target Site Selection for DNAzymes Using Secondary Structure and Hybridization Thermodynamics

Sirnas Target Sites Selection of Ezrin and the Influence of RNA Interference on Ezrin Expression and Biological Characters of Osteosarcoma Cells

["Target Secondary Structural Motif" in the Action of Antisense Oligodeoxynucleotides].

Designation and screening of ezrin mRNA target sites for DNAzymes in osteosarcoma and the validation in vitro

An Artificial Mirna Against Hpse Suppresses Melanoma Invasion Properties, Correlating With A Down-Regulation Of Chemokines And Mapk Phosphorylation

Optimization of antisense drug design against conservative local motif in simulant secondary structures of HER-2 mRNA and QSAR analysis.

Secondary Structure of Target RNA Impacts on RNA Interference Efficiency

Targeting RNA editing of antizyme inhibitor 1: A potential oligonucleotide-based antisense therapy for cancer

Antisense Drug Targeting with VEGF Mrna Designed by Computer Aid and Inhibitory Effects on K562 Cell Line in Vitro

Selection of Effective Bcl-2 Antisense Oligodeoxynucleotides with Computer Software and Experimental Assay

RNA Structural Dynamics Modulate EGFR-TKI Resistance Through Controlling YRDC Translation in NSCLC Cells

Rational design and rapid screening of antisense oligonucleotides for prokaryotic gene modulation

Positional Effect of Short Interfering RNAs Expressing Vector Targeting Human RAB5A

Antisense Candidates Against Protein Kinase C-alpha Designed Based on Phylogenesis and Simulant Structure of Mrna.

Structural Optimization and Additional Targets Identification of Antisense Oligonucleotide G3139 Encapsulated in a Neutral Cytidinyl-Lipid Combined with a Cationic Lipid in Vitro and in Vivo

Making target sites in large structured RNAs accessible to RNA-cleaving DNAzymes through hybridization with synthetic DNA oligonucleotides

Construction of small hairpin RNA expression vector and its function of silencing the ezrin gene

Recognition of RNA secondary structures with a programmable peptide nucleic acid-based platform

The Influence of Silencing Ezrin Expression by RNA Interference on the Biological Behaviors of Colorectal Carcinoma in Vitro

ANTISENSE OLIGONUCLEOTIDES: FROM DESIGN TO THERAPEUTIC APPLICATION